Cell And Gene Therapy Upstream Optimization
-
Auto, Allo, And AI
8/18/2023
CTO experts debate autologous and allogeneic, and how automation improves the CAR-T cell process every step from collection to infusion. They also discuss the major ways AI optimizes automation.
-
Scalable Production Of Lentivirus For Research To Commercial Manufacturing
10/30/2024
Join our webinar on scaling the CTS LV-MAX System in bioreactors, covering transfection scalability, Thermo S.U.B. advantages, and DynaSpin’s efficient gene therapy integration.
-
Accelerating Cell Culture Media Manufacturing: From Rapid Prototyping Through cGMP
6/5/2025
Industry leaders addressing effective ways to help streamline media manufacturing, including rapid small scale non-cGMP media prototyping and proprietary media formulation outsourcing options.
-
Supporting Efficacy And Scaling With A Next-Generation T Cell AOF Formulation Medium
6/16/2025
Explore a novel, next-generation medium designed with an animal component-free formulation to boost therapeutic potential and enable reproducible T cells.
-
Safety And Efficiency Of Source Material Collection
8/18/2023
Expert CTO's detail how automation improves safety and efficiency when collecting source material.
-
Multi-Omics And Bioinformatics In Cell Culture Media Design
6/16/2025
Learn about the impact of a multi-omics analysis, utilizing proteomics and metabolomics, in the development and optimization of media with the goal of improving titer, and making development and manufacturing more efficient.
-
Leveraging Rapid Sterility Testing To Advance Cell Therapy Production
6/23/2025
Explore the crucial role of rapid sterility testing in cell therapy manufacturing. This presentation delves into the benefits of swift, accurate detection for product quality and patient safety.
-
Dry Powder Media Manufacturing Grand Island Expansion
11/5/2025
Take a video tour of our newly expanded dry powder media manufacturing facility in Grand Island, New York. The expansion has added more than 45,000 square feet of Animal Origin Free (AOF) manufacturing space to help meet increasing global demand.
-
Advanced Granulation Technology (AGT) Cell Culture
11/4/2019
This video is an overview of the most advanced media format available for cell culture - AGT. A granular dry media format produced through a technologically advanced process which allows manufacturing of complete formulations in a dry format. It can be used in both fed-batch and perfusion cell cultures. AGT dry media is ready-to-use at target pH and osmolality. It is available in complete serum-free, protein-free and chemically-defined media formulations
-
CTS DynaCellect Magnetic Separation System Cell Isolation
5/22/2025
Ready to achieve high-purity results in your cell therapy manufacturing? This step-by-step guide demonstrates the complete setup and installation for your automated magnetic cell isolation system and kit.